Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Utah Medical Products (UTMD) EBT (2016 - 2025)

Utah Medical Products has reported EBT over the past 16 years, most recently at -$8.7 million for Q4 2025.

  • Quarterly results put EBT at -$8.7 million for Q4 2025, down 7466.1% from a year ago — trailing twelve months through Dec 2025 was $2.3 million (down 82.63% YoY), and the annual figure for FY2025 was $2.3 million, down 82.62%.
  • EBT for Q4 2025 was -$8.7 million at Utah Medical Products, down from $3.3 million in the prior quarter.
  • Over the last five years, EBT for UTMD hit a ceiling of $5.3 million in Q3 2022 and a floor of -$8.7 million in Q4 2025.
  • Median EBT over the past 5 years was $4.2 million (2024), compared with a mean of $2.5 million.
  • Biggest five-year swings in EBT: surged 144.06% in 2021 and later crashed 7466.1% in 2025.
  • Utah Medical Products' EBT stood at -$1.9 million in 2021, then tumbled by 38.22% to -$2.6 million in 2022, then crashed by 137.29% to -$6.2 million in 2023, then skyrocketed by 101.92% to $118000.0 in 2024, then crashed by 7466.1% to -$8.7 million in 2025.
  • The last three reported values for EBT were -$8.7 million (Q4 2025), $3.3 million (Q3 2025), and $3.8 million (Q2 2025) per Business Quant data.